Abridge, a trailblazer in AI medical records, has successfully secured $300 million in Series E funding, catapulting its valuation to approximately $5.3 billion. The round was spearheaded by Andreessen Horowitz, with notable participation from Khosla Ventures. Over the course of its seven-year operation, Abridge has diligently focused on leveraging AI in medical records, fostering a profound partnership with Epic Systems. In the initial quarter of fiscal year 2025, the company boasted an impressive $117 million in annual recurring revenue.

Moreover, Abridge has introduced an AI-driven medical coding service, significantly broadening its business horizons and intensifying competition with industry players like CodaMetrix. This innovative technology has been embraced by over 150 prominent healthcare systems throughout the United States, underscoring Abridge's robust growth trajectory and substantial market penetration.